Table 1. Clinicopathological characteristics of resected patients with mucinous pancreatic cystic neoplasms.
| Characteristics | n = 245 |
|---|---|
| Age, years (median, IQR) | 58 (48-65) |
| Sex (n, %) | |
| Female | 149 (60.8%) |
| Male | 96 (39.2%) |
| Symptom, present (n, %) | 116 (47.3%) |
| Tumor size, mm (median, IQR) | 35 (20-54) |
| Main pancreatic duct diameter ≥ 10 mm (n, %) | 28 (11.4%) |
| Surgical style (n, %) | |
| Pancreatoduodenectomy | 89 (36.3%) |
| Distal pancreatectomy/spleen preserved | 120 (49.0%)/14 (11.7%) |
| Total pancreatectomy | 8 (3.3%) |
| Middle segmentectomy | 12 (4.9%) |
| Enucleation | 16 (6.5%) |
| Harvested lymph nodes, n (median, IQR) | 4 (0-8) |
| Pathology (n, %) | |
| Intraductal papillary mucinous neoplasm | 162 (66.1%) |
| Main duct | 55 (34.0%) |
| Mixed type | 35 (21.6%) |
| Branch duct | 58 (35.8%) |
| Unknown | 14 (8.6%) |
| Mucinous cystic neoplasm | 83 (33.9%) |
| Albumin, g/L (median, IQR) | 40 (38-42) |
| CA19-9, U/mL (median, IQR) | 12.6 (7.0-25.1) |
| Unknown (n, %) | 10 (4.1%) |
| CEA, ng/mL (median, IQR) | 2.0 (1.3-3.2) |
| Unknown (n, %) | 11 (4.5%) |
| Platelet count, × 109/L (median, IQR) | 199 (164-236) |
| White blood cell count, × 109/L (median, IQR) | 5.3 (4.5-6.1) |
| Neutrophil count, × 109/L (median, IQR) | 2.9 (2.2-3.6) |
| Lymphocyte count, × 109/L (median, IQR) | 1.8 (1.5-2.1) |
| Monocyte count, × 109/L (median, IQR) | 0.36 (0.29-0.47) |
| Platelet-to-lymphocyte ratio (median, IQR) | 110.0 (92.6-141.7) |
| Neutrophil-to-lymphocyte ratio (median, IQR) | 1.61 (1.21-2.13) |
| Lymphocyte-to-monocyte ratio (median, IQR) | 4.88 (3.70-6.35) |
CA19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; IQR, interquartile range.